Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Johnson

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|September 9, 2022
A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human MonocytesKanut Laoharawee, Matthew J Johnson, Walker S Lahr, et al.
Cytotherapy|July 17, 2025
Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancersMatthew J Johnson, Darin Sumstad, Timothy D Folsom, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2026
Efficient multiplex non-viral engineering and expansion of polyclonal γδ CAR-T cells for immunotherapyJacob Bridge, Matthew J Johnson, Bibekananda Kar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 16, 2012
Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicityMatthew J Johnson, Constantinos Petrovas, Takuya Yamamoto, et al.
Communications Biology|January 24, 2026
CISH, a key intracellular checkpoint, in comparison and combination to existing and emerging cancer immune checkpointsFlorencia Cano, Alberto Bravo-Blas, Mathilde Colombe, et al.
Nature Biomedical Engineering|December 13, 2023
Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repairBeau R Webber, Matthew J Johnson, Joseph G Skeate, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2017
Systems analysis of protective immune responses to RTS,S malaria vaccination in humansDmitri Kazmin, Helder I Nakaya, Eva K Lee, et al.
Nature Communications|November 21, 2019
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Nature Communications|December 8, 2019
Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
The Journal of Nutrition|January 11, 2022
Body Composition and Cardiometabolic Risk Markers in Children of Women who Took Part in a Randomized Controlled Trial of a Preconceptional Nutritional Intervention in Mumbai, IndiaSirazul Ameen Sahariah, Meera Gandhi, Harsha Chopra, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|September 9, 2022
A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human MonocytesKanut Laoharawee, Matthew J Johnson, Walker S Lahr, et al.
Cytotherapy|July 17, 2025
Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancersMatthew J Johnson, Darin Sumstad, Timothy D Folsom, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2026
Efficient multiplex non-viral engineering and expansion of polyclonal γδ CAR-T cells for immunotherapyJacob Bridge, Matthew J Johnson, Bibekananda Kar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 16, 2012
Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicityMatthew J Johnson, Constantinos Petrovas, Takuya Yamamoto, et al.
Communications Biology|January 24, 2026
CISH, a key intracellular checkpoint, in comparison and combination to existing and emerging cancer immune checkpointsFlorencia Cano, Alberto Bravo-Blas, Mathilde Colombe, et al.
Nature Biomedical Engineering|December 13, 2023
Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repairBeau R Webber, Matthew J Johnson, Joseph G Skeate, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 2017
Systems analysis of protective immune responses to RTS,S malaria vaccination in humansDmitri Kazmin, Helder I Nakaya, Eva K Lee, et al.
Nature Communications|November 21, 2019
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
Nature Communications|December 8, 2019
Author Correction: Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editorsBeau R Webber, Cara-Lin Lonetree, Mitchell G Kluesner, et al.
The Journal of Nutrition|January 11, 2022
Body Composition and Cardiometabolic Risk Markers in Children of Women who Took Part in a Randomized Controlled Trial of a Preconceptional Nutritional Intervention in Mumbai, IndiaSirazul Ameen Sahariah, Meera Gandhi, Harsha Chopra, et al.
Pageof 7